Hammoudi, Nadjib
Jeong, Dongtak
Singh, Rajvir
Farhat, Ahmed
Komajda, Michel
Mayoux, Eric
Hajjar, Roger
Lebeche, Djamel http://orcid.org/0000-0002-7911-2923
Funding for this research was provided by:
National Institutes of Health (HL097357)
Boehringer Ingelheim (Agr-6547)
Article History
First Online: 22 June 2017
Compliance with Ethical Standards
:
: Some of the results in this paper have been published previously in an abstract at the American Diabetes Association 76th Scientific Sessions Boston, in June 2015. DL received unrestricted funding for an investigator initiated proposal from Boerhinger Ingelheim to perform this study. EM is an employee of Boehringer Ingelheim. Dr. Komajda has performed consulting/advisory activities for Servier, Bristol-Myers Squibb, AstraZeneca, Menarini, Novartis, MSD, and Sanofi-Aventis. All other authors declare no interests.
: Animals were obtained and handled as approved by the Mount Sinai Institutional Animal Care and Use Committee in accordance with the “Principles of Laboratory Animal Care by the National Society for Medical research and the Guide for the Care and Use of Laboratory Animals” (National Institutes of Health Publication No. 86-23, revised 1996).
: Not applicable.
: Not applicable.